Skip to content

CareDx CDNA Operating lease right-of-use asset amortization

Operating lease right-of-use asset amortization at other companies

BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
Teladoc Health logo
Teladoc HealthTDOC
Labcorp Holdings logo
Labcorp HoldingsLH

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B+32.2%
Enterprise value$1.35B+34.6%
P/S3.4×+0.3×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's operating lease right-of-use asset amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's operating lease right-of-use asset amortization?
CareDx (CDNA) reported operating lease right-of-use asset amortization of $1.42M in Q1 2026.
How has CareDx's operating lease right-of-use asset amortization changed year-over-year?
CareDx's operating lease right-of-use asset amortization increased by 5.9% year-over-year, from $1.34M to $1.42M.
What is the long-term trend for CareDx's operating lease right-of-use asset amortization?
Over 4 years (2021 to 2025), CareDx's operating lease right-of-use asset amortization has grown at a 15.0% compound annual growth rate (CAGR), from $3.09M to $5.4M.